Danmark -
dansk -
SEGES Landbrug & Fødevarer
raxil im 035 es flydende middel
bayer a/s - tebuconazol, imazalil - flydende middel - 15 g/l tebuconazol ; 20 g/l imazalil
Danmark -
dansk -
SEGES Landbrug & Fødevarer
dipel es flydende middel
cillus a/s - bacilus - flydende middel - 17600 itu/mg bacilus thuringiensis var. kurstaki
Danmark -
dansk -
SEGES Landbrug & Fødevarer
merit gran es suspensionskoncentrat
2022 environmental science fr s.a.s. - spirotetramat - suspensionskoncentrat - 100 g/l spirotetramat
Danmark -
dansk -
SEGES Landbrug & Fødevarer
quartz es suspensionskoncentrat
2022 environmental science fr s.a.s. - diflufenican - suspensionskoncentrat - 500 g/l diflufenican
Danmark -
dansk -
SEGES Landbrug & Fødevarer
proxy es vandopløseligt koncentrat
2022 environmental science fr s.a.s. - ethephon - vandopløseligt koncentrat - 480 g/l ethephon
Danmark -
dansk -
SEGES Landbrug & Fødevarer
herbaprop es 500 flydende middel
kvk agro a/s - mechlorprop - flydende middel - 500 g/l mechlorprop
Danmark -
dansk -
SEGES Landbrug & Fødevarer
herbatox-m 500 es flydende middel
kvk agro a/s - mcpa - flydende middel - 500 g/l mcpa
Danmark -
dansk -
SEGES Landbrug & Fødevarer
apron xl 350 es emulsionskoncentrat
syngenta nordics a/s - metalaxyl-m - emulsionskoncentrat - 350 g/l metalaxyl-m
Den Europæiske Union -
dansk -
EMA (European Medicines Agency)
imfinzi
astrazeneca ab - durvalumab - carcinom, ikke-småcellet lunge - antineoplastiske midler - non-small cell lung cancer (nsclc)imfinzi as monotherapy is indicated for the treatment of locally advanced, unresectable non small cell lung cancer (nsclc) in adults whose tumours express pd-l1 on ≥ 1% of tumour cells and whose disease has not progressed following platinum based chemoradiation therapy (see section 5. imfinzi in combination with tremelimumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic nsclc with no sensitising egfr mutations or alk positive mutations. small cell lung cancer (sclc)imfinzi in combination with etoposide and either carboplatin or cisplatin is indicated for the first-line treatment of adults with extensive-stage small cell lung cancer (es-sclc). biliary tract cancer (btc)imfinzi in combination with gemcitabine and cisplatin is indicated for the first line treatment of adults with unresectable or metastatic biliary tract cancer (btc). hepatocellular carcinoma (hcc)imfinzi in combination with tremelimumab is indicated for the first line treatment of adults with advanced or unresectable hepatocellular carcinoma (hcc).